Invesaro

Stocks AVT Financial statements

Financial statements

AVNET INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AVNET INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue17,44019,03719,51917,63419,53524,31126,53723,75722,20127,633
Cost of revenue15,07116,51017,03215,57117,29421,34523,35520,99119,81624,751
Gross profit2,3692,5272,4862,0632,2412,9653,1822,7662,3852,882
Selling, general and administrative1,7881,9911,8751,8421,8751,9951,9671,8701,7622,022
Operating income444209366-4.632819391,187844514725
Interest expense99.692.713512389.5100251283246251
Other non-operating income-33.728.65.56-2.22-19-5.39.91-15.7-17.3-6.63
Pre-tax income310145237-130173833983632251467
Income tax47.128860.3-98.5-20.214121213410.4133
Net income525-156176-31.1193692771499240334
EBITDA5994445471784131,0411,275931586802
EPS, basic4.13-1.301.61-0.311.957.028.375.512.784.07
EPS, diluted4.08-1.301.59-0.311.936.948.265.432.754.01
Shares, basic (weighted)12712011010099.398.79290.686.382.2
Shares, diluted (weighted)12912011110010099.893.491.887.483.4
Dividend per share0.700.740.800.840.851.001.161.241.321.40

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents836621546477200154288311192155
Receivables3,3383,6413,1682,9283,5764,3014,7644,3914,3276,883
Inventory2,8253,1423,0082,7323,2374,2445,4655,4695,2356,069
Other current assets254207153191151178234200263226
Total current assets7,5347,6116,8766,3297,1638,87710,75110,37110,01913,334
Property, plant and equipment520523452405369315442568667645
Lease right-of-use assets276266227222209202249
Goodwill1,148981877774838759781781837810
Intangible assets27722014465.428.512.76.5
Other non-current assets221263216257261211282280394388
Total assets9,7009,5978,5658,1058,92510,38912,47712,20912,11915,425
Accounts payable1,8622,2691,8641,7542,4013,4323,3743,3463,4876,054
Accrued liabilities542535414473572591753573497659
Short-term debt50.11653010.0523.117470.649387.3734
Total current liabilities2,4542,9692,5792,2803,0554,2524,2494,4654,1287,503
Long-term debt1,7291,4891,4201,4251,1911,4372,9882,4072,5752,479
Lease liabilities254240199191174159207
Other non-current liabilities335453426420355307297238245213
Total liabilities4,5184,9124,4244,3794,8416,1967,7257,2847,10710,403
Total debt1,7291,4891,4201,4251,1911,4372,9882,4072,5752,479
Paid-in capital1,5031,5291,5731,5941,6221,6571,6911,7211,7551,803
Retained earnings3,7993,2362,7672,4222,5162,9213,3783,6023,4303,513
Other comprehensive income-244-195-304-388-154-481-409-487-258-375
Shareholders' equity5,1824,6854,1403,7264,0844,1934,7524,9265,0115,023
Total equity5,1824,6854,1403,7264,0844,1934,7524,9265,0115,023
Total liabilities and equity9,7009,5978,5658,1058,92510,38912,47712,20912,11915,425

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income525-156176-31.1193692771499240334
Depreciation and amortization15523518118213210288.686.771.676.8
Stock-based compensation47.72430.126.829.336.738.833.536.448.7
Deferred income tax-18.2-68.8-6.74-12.125.5-53-33.5-16-99.61.28
Change in receivables-372-296465221-615-1,132-461316184-2,615
Change in inventory84.4-30981.9267-409-1,219-1,173-51.2410-918
Cash from operations-36925353573090.9-219-714690725-281
Capital expenditures-120-156-123-73.5-50.4-48.9-195-226-147-73.6
Acquisitions-803-15.3-56.4-51.5-18.4
Cash from investing1,33871.7-25.2-135-61.251.3-212-225-137-71.5
Stock issued25.29.220.20.94.95.7
Share buybacks-276-324-569-238-184-222-163-303-138
Dividends paid-88.7-88.3-87.2-84-84.3-98.5-106-112-113-114
Cash from financing-1,188-542-583-645-3141561,055-434-694316
Exchange rate effect23.3
Net change in cash-195-215-75-69.1-277-4613522.7-119-37
Free cash flow-48997.641265740.6-268-908464577-354
Interest paid11699.914513898.5112262351288270
Income taxes paid40411317325.183.46.89217209246107

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $103.08 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin10.4%Gross profit / revenue.
Operating margin2.6%Operating income / revenue.
EBITDA margin2.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin1.7%Pre-tax income / revenue.
Net margin1.2%Net income / revenue.
FCF margin-1.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-1.0%Cash from operations / revenue.
Effective tax rate28.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)6.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.4%Net income / average total assets.
Return on invested capital (ROIC)7.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue7.3%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.3%Capital expenditures / revenue.
D&A / revenue0.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y24.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y7.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y20.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-3.2%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y40.9%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-15.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y20.8%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y36.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-14.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y14.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y39.2%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-24.3%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y11.6%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y45.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-21.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y15.7%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-138.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-161.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y6.1%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y6.5%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y10.5%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y0.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y1.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y27.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y7.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y11.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-4.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-3.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-3.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.78xCurrent assets / current liabilities.
Quick ratio0.94x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.02x(Cash + short-term investments) / current liabilities.
Debt / equity0.49xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets16.1%Total debt / total assets.
Liabilities / assets67.4%Total liabilities / total assets.
Net debt$2.32BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.90xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage2.89xOperating income / interest expense.
Working capital$5.83BCurrent assets - current liabilities.
Goodwill and intangibles / assets5.3%(Goodwill + intangible assets) / total assets.
Tangible book value$4.21BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover2.01xRevenue / average total assets.
Fixed asset turnover42.1xRevenue / average property, plant and equipment.
Inventory turnover4.38xCost of revenue / average inventory.
Days inventory83 days365 x average inventory / cost of revenue.
Receivables turnover4.93xRevenue / average receivables.
Days sales outstanding74 days365 x average receivables / revenue.
Days payables70 days365 x average accounts payable / cost of revenue.
Cash conversion cycle87 daysDays inventory + days sales outstanding - days payables.
FCF conversion-106.0%Free cash flow / net income, when net income is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$4.01Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$4.07Net income per basic share, as reported (split-adjusted).
Revenue per share$331.27Revenue / diluted weighted shares.
FCF per share-$4.25Free cash flow / diluted weighted shares.
Operating cash flow per share-$3.37Cash from operations / diluted weighted shares.
Book value per share$60.21Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$50.50Tangible book value / shares outstanding.
Cash per share$1.86(Cash + short-term investments) / shares outstanding.
Dividend per share$1.40Dividend declared per common share (paid, when declared is not tagged).
Payout ratio34.2%Dividends paid / net income, when net income is positive.

Valuation

MetricValueHow it is calculated
Market cap$8.46BShare price x shares outstanding.
Enterprise value$10.78BMarket cap + total debt - cash - short-term investments.
P/E25.3xMarket cap / net income. Only when net income is positive.
P/S0.31xMarket cap / revenue.
P/B1.68xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.01xMarket cap / tangible book value, when positive.
EV/Sales0.39xEnterprise value / revenue.
EV/EBIT14.9xEnterprise value / operating income, when both are positive.
EV/EBITDA13.5xEnterprise value / EBITDA, when both are positive.
FCF yield-4.2%Free cash flow / market cap.
Earnings yield4.0%Net income / market cap (the inverse of P/E).
Dividend yield1.4%Dividends paid over the period / market cap.
Shareholder yield3.0%(Dividends paid + share buybacks) / market cap.
What was AVNET INC's revenue in fiscal 2026?

AVNET INC reported revenue of $27.63B for fiscal 2026, 24.5% higher than the year before.

Was AVNET INC profitable in fiscal 2026?

Yes. Net income was $334.4M, a net margin of 1.2%.

How much free cash flow did AVNET INC generate in fiscal 2026?

Cash from operations of $280.9M minus capital expenditures of $73.6M left free cash flow of -$354.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AVNET INC